Pirolli R, de Alencar VTL, Estati FL, Ribeiro ARG, et al. Comparison of dose-dense vs. 3-weekly paclitaxel and carboplatin in the first-line treatment of ovarian cancer in a propensity score-matched cohort. BMC Cancer 2021;21:525.
PMID: 33964923